• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经相关热潮红的持续时间及其相关危险因素。

Duration of menopausal hot flushes and associated risk factors.

机构信息

From the Department of Obstetrics/Gynecology, the Center for Clinical Epidemiology and Biostatistics, and the Center for Research in Reproduction and Women's Health, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and the Division of Biostatistics, Department of Medicine, Indiana University, Indianapolis, Indiana.

出版信息

Obstet Gynecol. 2011 May;117(5):1095-1104. doi: 10.1097/AOG.0b013e318214f0de.

DOI:10.1097/AOG.0b013e318214f0de
PMID:21508748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3085137/
Abstract

OBJECTIVE

To estimate the duration of moderate-to-severe menopausal hot flushes and identify potential risk factors for hot flush duration.

METHODS

The Penn Ovarian Aging Study cohort was monitored for 13 years. Hot flushes were evaluated at 9-month to 12-month intervals through in-person interviews. The primary outcome was the duration of moderate-to-severe hot flushes estimated by survival analysis (n=259). Potential risk factors included menopausal stage, age, race, reproductive hormone levels, body mass index (BMI), and current smoking. A secondary analysis included women who reported any hot flushes (n=349).

RESULTS

The median duration of moderate-to-severe hot flushes was 10.2 years and was strongly associated with menopausal stage at onset. Hot flushes that started near entry into the menopause transition had a median duration greater than 11.57 years; onset in the early transition stage had a median duration of 7.35 years (95% confidence interval [CI] 4.94-8.89; P<.001); and onset in the late transition to postmenopausal stages had a median duration of 3.84 years (95% CI 1.77-5.52; P<.001). The most common ages at onset of moderate-to-severe hot flushes were 45-49 years (median duration, 8.1 years; 95% CI 5.12-9.28). African American women had a longer duration of hot flushes than white women in adjusted analysis.

CONCLUSION

The median duration of hot flushes considerably exceeded the timeframe that is generally accepted in clinical practice. The identified risk factors, particularly menopausal stage, race, and BMI, are important to consider in individualizing treatment and evaluating the risk-to-benefit ratio of hormones and other therapies.

摘要

目的

评估中重度绝经相关潮热的持续时间,并确定潮热持续时间的潜在风险因素。

方法

宾夕法尼亚绝经衰老研究队列进行了 13 年的监测。通过面对面访谈,每 9-12 个月评估一次潮热。主要结局是通过生存分析评估中重度潮热的持续时间(n=259)。潜在的风险因素包括绝经阶段、年龄、种族、生殖激素水平、体重指数(BMI)和当前吸烟状况。二次分析包括报告有任何潮热的女性(n=349)。

结果

中重度潮热的中位数持续时间为 10.2 年,与起始时的绝经阶段密切相关。在绝经过渡接近开始时出现的潮热中位数持续时间超过 11.57 年;在早期过渡阶段开始的中位持续时间为 7.35 年(95%置信区间 [CI] 4.94-8.89;P<.001);在晚期过渡到绝经后阶段开始的中位持续时间为 3.84 年(95% CI 1.77-5.52;P<.001)。中重度潮热最常见的起始年龄为 45-49 岁(中位数持续时间 8.1 年;95% CI 5.12-9.28)。在调整分析中,非裔美国女性的潮热持续时间长于白人女性。

结论

潮热的中位数持续时间大大超过了临床上普遍接受的时间框架。确定的风险因素,特别是绝经阶段、种族和 BMI,在个体化治疗和评估激素和其他疗法的风险-效益比方面非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/3085137/7db1526ad203/nihms280110f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/3085137/bbea1db6ec61/nihms280110f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/3085137/7db1526ad203/nihms280110f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/3085137/bbea1db6ec61/nihms280110f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/3085137/7db1526ad203/nihms280110f2.jpg

相似文献

1
Duration of menopausal hot flushes and associated risk factors.绝经相关热潮红的持续时间及其相关危险因素。
Obstet Gynecol. 2011 May;117(5):1095-1104. doi: 10.1097/AOG.0b013e318214f0de.
2
The role of anxiety and hormonal changes in menopausal hot flashes.焦虑和激素变化在更年期潮热中的作用。
Menopause. 2005 May-Jun;12(3):258-66. doi: 10.1097/01.gme.0000142440.49698.b7.
3
Duration of menopausal vasomotor symptoms over the menopause transition.绝经过渡期间绝经血管舒缩症状的持续时间。
JAMA Intern Med. 2015 Apr;175(4):531-9. doi: 10.1001/jamainternmed.2014.8063.
4
Obesity, smoking, and risk of vasomotor menopausal symptoms: a pooled analysis of eight cohort studies.肥胖、吸烟与血管舒缩性绝经症状风险:八项队列研究的汇总分析。
Am J Obstet Gynecol. 2020 May;222(5):478.e1-478.e17. doi: 10.1016/j.ajog.2019.10.103. Epub 2019 Nov 6.
5
Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.神经激肽 3 受体拮抗剂作为治疗更年期潮热的一种新方法:一项 2 期、随机、双盲、安慰剂对照试验。
Lancet. 2017 May 6;389(10081):1809-1820. doi: 10.1016/S0140-6736(17)30823-1. Epub 2017 Apr 3.
6
Is core temperature the trigger of a menopausal hot flush?核心体温是更年期热潮的触发因素吗?
Menopause. 2019 Sep;26(9):1016-1023. doi: 10.1097/GME.0000000000001357.
7
Increased vascular inflammation in early menopausal women is associated with hot flush severity.绝经早期女性血管炎症增加与热潮红严重程度相关。
J Clin Endocrinol Metab. 2012 May;97(5):E760-4. doi: 10.1210/jc.2011-3151. Epub 2012 Mar 7.
8
Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women.生殖后期的潮热:非裔美国女性和白人女性的风险因素。
J Womens Health Gend Based Med. 2001 Jan-Feb;10(1):67-76. doi: 10.1089/152460901750067133.
9
Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes.绝经早期内皮功能受到影响,而颈动脉内膜中层厚度不受影响,且与热潮红严重程度相关。
J Clin Endocrinol Metab. 2010 Mar;95(3):1199-206. doi: 10.1210/jc.2009-2262. Epub 2010 Jan 15.
10
Association of hot flushes with ghrelin and adipokines in early versus late postmenopausal women.绝经早期和晚期女性中热潮红与ghrelin 和脂肪因子的关系。
Menopause. 2020 May;27(5):512-518. doi: 10.1097/GME.0000000000001508.

引用本文的文献

1
Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer risk.巴多昔芬/共轭雌激素在肥胖相关乳腺癌风险模型中的代谢和转录效应
JCI Insight. 2025 Mar 6;10(8). doi: 10.1172/jci.insight.182694. eCollection 2025 Apr 22.
2
A Systematic Review of Anxiety and Depressive Symptoms Among Women Experiencing Vasomotor Symptoms Across Reproductive Stages in the US.美国不同生殖阶段出现血管舒缩症状的女性焦虑和抑郁症状的系统评价
Int J Womens Health. 2025 Feb 27;17:537-552. doi: 10.2147/IJWH.S491640. eCollection 2025.
3
Effects of physical activity on menopausal symptoms, psychosomatic factors and well-being among working women in England: A path analysis.

本文引用的文献

1
Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.绝经过渡期血管舒缩症状与骨转换增加的相关性。
J Bone Miner Res. 2011 Apr;26(4):840-9. doi: 10.1002/jbmr.259.
2
Evaluation and management of sleep disturbance during the menopause transition.围绝经期睡眠障碍的评估与管理。
Semin Reprod Med. 2010 Sep;28(5):404-21. doi: 10.1055/s-0030-1262900. Epub 2010 Sep 15.
3
Obesity and reproductive hormone levels in the transition to menopause.绝经过渡期的肥胖与生殖激素水平。
体力活动对英国职业女性更年期症状、身心因素和幸福感的影响:路径分析。
Womens Health (Lond). 2024 Jan-Dec;20:17455057241290370. doi: 10.1177/17455057241290370.
4
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control.克服早期乳腺癌预防试验中的挑战:巴多昔芬和结合雌激素与安慰剂对照。
Contemp Clin Trials. 2024 Nov;146:107697. doi: 10.1016/j.cct.2024.107697. Epub 2024 Sep 17.
5
Effects of HN001 on Happiness and Mental Well-Being: Findings from a Randomized Controlled Trial.HN001 对幸福感和心理健康的影响:一项随机对照试验的结果。
Nutrients. 2024 Sep 2;16(17):2936. doi: 10.3390/nu16172936.
6
Comparing Cancer Risks and Mortality between Phytopharmaceuticals and Estrogen-Progestogen Medications for Menopausal Women: A Population-Based Cohort Study.比较植物药与雌激素 - 孕激素药物对绝经后女性的癌症风险和死亡率:一项基于人群的队列研究。
Healthcare (Basel). 2024 Jun 19;12(12):1220. doi: 10.3390/healthcare12121220.
7
Hormones as Psychotropic Interventions in Females.激素作为女性精神药物干预手段
Focus (Am Psychiatr Publ). 2024 Jan;22(1):63-66. doi: 10.1176/appi.focus.20230031. Epub 2024 Jan 12.
8
Does everyday discrimination account for the increased risk of vasomotor symptoms in Black women?: the Study of Women's Health Across the Nation (SWAN).日常歧视是否解释了黑人女性血管舒缩症状风险增加的原因?:妇女健康全国性研究(SWAN)。
Menopause. 2024 Jun 1;31(6):484-493. doi: 10.1097/GME.0000000000002357. Epub 2024 Apr 9.
9
Prospective early adulthood risk factors for vasomotor symptoms in the Coronary Artery Risk Development in Young Adults study.冠状动脉风险发展在年轻人研究中前瞻性的成年早期血管舒缩症状的危险因素。
Menopause. 2024 Feb 1;31(2):108-115. doi: 10.1097/GME.0000000000002306.
10
Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial.口服微粒化黄体酮治疗围绝经期夜间盗汗和热潮红:一项为期 4 个月、加拿大全国范围、随机、安慰剂对照、III 期试验。
Sci Rep. 2023 Jun 5;13(1):9082. doi: 10.1038/s41598-023-35826-w.
Menopause. 2010 Jul;17(4):718-26. doi: 10.1097/gme.0b013e3181cec85d.
4
History of hot flashes and aortic calcification among postmenopausal women.绝经后女性的热潮红史和主动脉钙化。
Menopause. 2010 Mar;17(2):256-61. doi: 10.1097/gme.0b013e3181c1ad3d.
5
Hot flashes and cardiac vagal control: a link to cardiovascular risk?热潮和心脏迷走神经控制:与心血管风险有关吗?
Menopause. 2010 May-Jun;17(3):456-61. doi: 10.1097/gme.0b013e3181c7dea7.
6
Role of ethnicity in the expression of features of hot flashes.种族在潮热症状表现中的作用。
Maturitas. 2009 Aug 20;63(4):341-6. doi: 10.1016/j.maturitas.2009.06.002. Epub 2009 Jul 9.
7
Menopause and sexuality: prevalence of symptoms and impact on quality of life.更年期与性:症状患病率及其对生活质量的影响。
Maturitas. 2009 Jun 20;63(2):138-41. doi: 10.1016/j.maturitas.2009.03.021. Epub 2009 May 21.
8
On hot flash mechanism, measurement, and treatment.关于潮热的机制、测量与治疗。
Menopause. 2009 Jul-Aug;16(4):621-3. doi: 10.1097/gme.0b013e3181a85107.
9
Depressive symptoms and menopausal burden in the midlife.中年时期的抑郁症状与更年期负担
Maturitas. 2009 Mar 20;62(3):306-10. doi: 10.1016/j.maturitas.2009.01.002. Epub 2009 Feb 14.
10
Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode.女性的血管舒缩症状与抑郁,第一部分。血管舒缩症状在提示重度抑郁发作的开始或复发中的作用。
J Clin Psychiatry. 2009 Jan;70(1):11-2. doi: 10.4088/jcp.08bs04900.